Additional file 4 of Developing a disease-specific accessible transcriptional signature as a biomarker for ataxia with oculomotor apraxia type 2

Supplementary Material 4: Supplemental Table S1. Detailed Characteristics of the 20 families included in this study. Supplemental Table S2. Blood RNA-seq Module Membership. Supplemental Table S3. Module R05 Gene Ontology. Supplemental Table S4. Module R10 Gene Ontology. Supplemental Table S5. Module R20 Gene Ontology. Supplemental Table S6. Module R22 Gene Ontology. Supplemental Table S7. Module R23 Gene Ontology. Supplemental Table S8. AOA2 Transcriptional Biomarker Validation. Supplemental Table S9. Differentially Expressed Genes and Gene Ontology.